Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 1999;58:136-141; doi:10.1136/ard.58.3.136
Copyright © 1999 BMJ Publishing Group Ltd & European League Against Rheumatism.
Ann Rheum Dis 1999;58:136-141 ( March )

Review

Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?

Christian Jorgensen, Florence Apparailly, Jacques Sany

Immuno-rheumatology Department, CHU Lapeyronie, 34295 Montpellier cedex 5 France

Correspondence to: Dr Jorgensen.

The first 150 words of the full text of this article appear below.

    Introduction

Over the past five years, several immunotherapy trials have been performed in autoimmune diseases by targeting interleukin 1beta (IL1beta ) (IL1 receptor antagonist (IL1-ra), IL-1 type I receptor), tumour necrosis factor (TNFalpha ) (mAb anti-TNFalpha , soluble receptor RTNFp55 or p75 fusion protein, TNF binding protein), interleukin 6 (IL6) or Th2 cytokines like recombinant human interleukin 10 (rhuIL10) (table 1).1 One limitation of attempts to target a single cytokine is the overlap of the immune effects of IL1, TNFalpha , and IL6. However, the clinical trials indicate that inhibition of a single cytokine, despite the complexity of the network, is efficient. Moreover, the inhibition of major cytokines involved in host defence was found to be relatively well tolerated in the short-term, and few infections were reported. Paradoxically, very few data are available concerning effects of systemic delivery of rhuIL10 or cytokine antagonist on the immune system. This review analyses the . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Zhu, Z., Stevenson, D., Schechter, J. E., Mircheff, A. K., Ritter, T., Labree, L., Trousdale, M. D. (2004). Prophylactic Effect of IL-10 Gene Transfer on Induced Autoimmune Dacryoadenitis. IOVS 45: 1375-1381 [Abstract] [Full Text]  
  • Byrne, A., Reen, D. J. (2002). Lipopolysaccharide Induces Rapid Production of IL-10 by Monocytes in the Presence of Apoptotic Neutrophils. J. Immunol. 168: 1968-1977 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs